Impact of prior cancer on eligibility for lung cancer clinical trials

DE Gerber, AL Laccetti, L Xuan… - … the National Cancer …, 2014 - academic.oup.com
… common malignancies, including lung cancer, there are no … the frequency and timing of prior
cancer diagnoses in oncology … prior cancer-related eligibility criteria in lung cancer clinical …

Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual

AL Laccetti, SL Pruitt, L Xuan, EA Halm… - … the National Cancer …, 2015 - academic.oup.com
… IV lung cancer patients with prior cancer diagnosis. We quantified the type and stage … prior
cancer in addition to time elapsed between the prior cancer diagnosis and index lung cancer

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.

G Giaccone, M Donadio, G Bonardi… - Journal of Clinical …, 1988 - ascopubs.org
… Fifty patients with small-cell lung cancer (SCLC) were treated with … Effectiveness of prior
chemotherapy and time from last … to prior treatment (ie, progressed while on treatment) or re- …

[HTML][HTML] Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer

SL Pruitt, AL Laccetti, L Xuan, EA Halm… - … journal of cancer, 2017 - nature.com
… that they will not tolerate aggressive lung cancer treatment or will have inferior outcomes, …
-modality treatment were simliar between patients with and without a prior cancer diagnosis. …

Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis

AL Laccetti, SL Pruitt, L Xuan, EA Halm, DE Gerber - Lung Cancer, 2016 - Elsevier
prior cancer may have better lung cancer-specific survival than those without a prior cancer
… but mirrors our findings among patients with metastatic lung cancer [19]. There are few other …

Erlotinib in previously treated non–small-cell lung cancer

FA Shepherd, J Rodrigues Pereira… - New England journal …, 2005 - Mass Medical Soc
… In an intention-to-treat analysis of all patients randomly assigned to treatment, the disease-…
-cell lung cancer was not significantly altered by performance status, prior treatments, prior

Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning

HT Winer-Muram, SG Jennings, RD Tarver, AM Aisen… - Radiology, 2002 - pubs.rsna.org
… volumes of lung cancers prior to treatment. The … prior to treatment ( , Figure). The purpose
of this study was to determine the range of growth rates of stage I lung cancers prior to treatment

Targeted therapies for treatment of non‐small cell lung cancer—recent advances and future perspectives

J Minguet, KH Smith, P Bramlage - … journal of cancer, 2016 - Wiley Online Library
… form of cancer. Over the last decades, lung cancer has been the leading cause of cancer-…
efficacy and safety of ceritinib in patients with and without prior treatment are ongoing.92 …

[HTML][HTML] Predicting lung cancer prior to surgical resection in patients with lung nodules

SA Deppen, JD Blume, MC Aldrich, SA Fletcher… - Journal of Thoracic …, 2014 - Elsevier
… model to help diagnose a suspected lung cancer without missing early stage disease; …
Treatment (TREAT) lung cancer prediction model and compared the performance of the TREAT

Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non–small cell lung cancer after failure of at least one prior chemotherapy …

JR Johnson, M Cohen, R Sridhara, YF Chen… - Clinical Cancer …, 2005 - AACR
… , on erlotinib treatment effect. Lung cancer is the leading cause of cancer death in both men
… Initial therapy for advanced non–small lung cancer (NSCLC) is systemic chemotherapy with …